Clinical Trials Browser

beta-Thalassemia × luspatercept × Clear all

NCT04064060 2025-11-12

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Phase 3 Recruiting

Myelodysplastic Syndromes, Myeloproliferative Disorders, beta-Thalassemia

NCT02604433 2023-04-18

BELIEVE

Phase 3 Completed

336 enrolled 38 charts 1 FDA

beta-Thalassemia